In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery. Clark J, Tong SYC. Ann Intern Med 2023 May 2. doi: 10.7326/J23-0025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clark J, Tong SYC. In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery. Ann Intern Med 2023 May 2. doi: 10.7326/J23-0025.
PMID: 37126816